PRMT1 and non-small cell lung carcinoma: Overall, this study demonstrated that the EMT biomarkers PRMT-1 and p120-catenin play an important role in activation of the EMT process, increasing the invasive characteristics of NSCLC and, thus, promoting Osimertinib-resistance.